HRP20190891T1 - Medicinski proizvod i tretman - Google Patents

Medicinski proizvod i tretman Download PDF

Info

Publication number
HRP20190891T1
HRP20190891T1 HRP20190891TT HRP20190891T HRP20190891T1 HR P20190891 T1 HRP20190891 T1 HR P20190891T1 HR P20190891T T HRP20190891T T HR P20190891TT HR P20190891 T HRP20190891 T HR P20190891T HR P20190891 T1 HRP20190891 T1 HR P20190891T1
Authority
HR
Croatia
Prior art keywords
medicine
use according
treatment
ibuprofen
paracetamol
Prior art date
Application number
HRP20190891TT
Other languages
English (en)
Croatian (hr)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20190891(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of HRP20190891T1 publication Critical patent/HRP20190891T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
HRP20190891TT 2008-10-14 2009-10-12 Medicinski proizvod i tretman HRP20190891T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
EP09820803.6A EP2341900B1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment
PCT/NZ2009/000220 WO2010044681A1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment

Publications (1)

Publication Number Publication Date
HRP20190891T1 true HRP20190891T1 (hr) 2019-07-12

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190891TT HRP20190891T1 (hr) 2008-10-14 2009-10-12 Medicinski proizvod i tretman

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201906742T4 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1781277T3 (pl) 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
JP2013541583A (ja) * 2010-11-04 2013-11-14 エイエフティ ファーマスーティカルズ リミテッド 組み合わせ組成物
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CN114681324B (zh) 2017-07-10 2024-05-03 盖尔凯普科技有限公司 双释放剂型胶囊及其制备方法、装置和系统
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
PL1781277T3 (pl) * 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
PL2341900T3 (pl) 2019-08-30
TR201102810T2 (tr) 2011-05-23
RU2011111792A (ru) 2012-11-27
ZA201101752B (en) 2012-02-29
EP2341900B1 (en) 2019-02-20
PT2341900T (pt) 2019-05-14
KR20110112279A (ko) 2011-10-12
DK2341900T3 (da) 2019-05-20
SI2341900T1 (sl) 2019-06-28
EP2341900A4 (en) 2012-02-29
GB201105249D0 (en) 2011-05-11
HUE043063T2 (hu) 2019-07-29
GB2476418B (en) 2013-04-24
MX2011003928A (es) 2011-08-12
CY1122198T1 (el) 2020-11-25
AU2009304002B2 (en) 2013-04-18
CH702339B1 (de) 2016-06-15
RU2487707C2 (ru) 2013-07-20
AU2009304002A1 (en) 2010-04-22
MA32635B1 (fr) 2011-09-01
NZ591496A (en) 2012-12-21
CL2011000678A1 (es) 2011-09-23
JP2012505830A (ja) 2012-03-08
CA2735834C (en) 2017-05-16
ES2725151T3 (es) 2019-09-19
LT2341900T (lt) 2019-04-10
CN102215835A (zh) 2011-10-12
GB2476418A (en) 2011-06-22
CO6341553A2 (es) 2011-11-21
EP2341900A1 (en) 2011-07-13
CA2735834A1 (en) 2010-04-22
AU2009304002B9 (en) 2014-06-26
MX340662B (es) 2016-07-20
WO2010044681A1 (en) 2010-04-22
TR201906742T4 (tr) 2019-05-21
BRPI0914086A2 (pt) 2020-01-21
MY153932A (en) 2015-04-15
US20110166234A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
HRP20190891T1 (hr) Medicinski proizvod i tretman
Nisar et al. Comparison of medicinally important natural products versus synthetic drugs-a short commentary
HRP20110659T1 (hr) Uporaba beta blokatora za proizvodnju lijeka za liječenje hemangioma
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
JP2012031131A5 (enExample)
JP2015038135A5 (enExample)
RU2010147287A (ru) Комбинированная композиция
MY162175A (en) Aqueous drug delivery system
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
JP2017512194A5 (enExample)
JP2012505830A5 (enExample)
BR112013012100A2 (pt) composição ou formulação farmacêutica adaptada para administração oral em forma de comprimido, comprimido revestido ou cápsula na prevenção ou tratamento de distúrbios intestinais, processo para preparar a composição ou formulação farmacêutica e uso da composição ou formulação farmacêutica
JP2019529559A5 (enExample)
AR076916A1 (es) Medicamento a base de calcio y de vitamina d. kit.
Soltanzad et al. Evaluation of cytotoxicity and anti-cancer effect of Ferula szowitsiana methanolic extract on lung cancer A549 cell-lines
JP2012046484A5 (enExample)
BR112012020415A2 (pt) composição farmacêutica para a prevenção ou tratamento da osteoartrite
NZ596881A (en) Phentermine liquid dosage form
Sonawane et al. An Innovative Approach
WO2018186650A3 (ko) 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
EP1949900A3 (en) Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof
HRP20160811T1 (hr) Upotreba odiparcila u liječenju mukopolisaharidoze
AR088369A1 (es) Sistema de administracion de farmaco de dos fases
Rini et al. Farmaci in odontoiatria: responsabilità e problematiche medico-legali
CN101475075A (zh) 固定复合包装药品